Recently stock market analysts have updated their consensus ratings on shares of Lifevantage Corporation (LFVN).
Most recent broker ratings
09/08/2014 – Midtown Partners began new coverage on Lifevantage Corporation giving the company a “buy” rating. They now have a USD 1.43 price target on the stock.
Lifevantage Corporation has a 50 day moving average of 10.48 and a 200 day moving average of 11.96. The stock’s market capitalization is 127.33M, it has a 52-week low of 4.87 and a 52-week high of 15.97.
The share price of the company (LFVN) was down -1.84% during the last trading session, with a high of 9.44 and the volume of Lifevantage Corporation shares traded was 59730.
LifeVantage Corporation is engaged in the identification, research, development and distribution of nutraceutical dietary supplements and skin care products. The Company’s products include Protandim, a dietary supplement that reduces the age-dependent growth in markers of oxidative stress; LifeVantage TrueScience, a line of anti-aging skin care products, which include TrueScience Ultra Gentle Facial Cleanser, TrueScience Perfecting Lotion, TrueScience Eye Corrector Serum and TrueScience Anti-Aging Cream; Canine Health, a pet supplement formulated to combat oxidative stress in dogs, and Axio, an energy drink mix formulated to promote alertness and support mental performance. The Company sells its products to an international network of independent distributors in the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico and Thailand.